Showing results (931-940 of 1,108) with videos related to

Sort By:
Pageof 111
Cancers|May 11, 2024
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in SpainDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.
Lancet (London, England)|December 6, 2020
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trialJavier Cortes, David W Cescon, Hope S Rugo, et al.
Biosensors|September 23, 2022
Integration of Multiple Interferometers in Highly Multiplexed Diagnostic KITs to Evaluate Several Biomarkers of COVID-19 in SerumAna María M Murillo, Luis G Valle, Yolanda Ramírez, et al.
Joint Bone Spine|May 2, 2025
Active hand inflammation. Differing clinical and ultrasound patterns in patients with rheumatoid arthritis and psoriatic arthritis - A Cross-Sectional, Multicenter StudyJulio Ramírez, Vicenç Torrente-Segarra, Andrea Cuervo, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 4, 2021
Identification of plasma proteins relating to brain neurodegeneration and vascular pathology in cognitively normal individualsLiu Shi, Colin R Buchanan, Simon R Cox, et al.
Translational Psychiatry|November 1, 2025
Interplay between age, APOE Ɛ4 and the metabolome in plasma and brain in Alzheimer's diseaseNajaf Amin, Jun Liu, William Sproviero, et al.
Viruses|January 19, 2018
Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?Gabriela Turk, Yanina Ghiglione, Macarena Hormanstorfer, et al.
Frontiers in Immunology|October 27, 2018
Elevated Autoantibodies in Subacute Human Spinal Cord Injury Are Naturally Occurring AntibodiesAngel Arevalo-Martin, Lukas Grassner, Daniel Garcia-Ovejero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockadeP Nuciforo, T Pascual, J Cortés, et al.
Metabolites|March 29, 2023
Neurodegeneration, Mitochondria, and AntibioticsJuan M Suárez-Rivero, Juan López-Pérez, Inés Muela-Zarzuela, et al.
Pageof 111